After establishing a relationship between NK cell suppression and SIRT2-mediated melanoma growth, we hypothesized that pharmacological inhibition of SIRT2 function in vivo would have a therapeutic effect on tumor progression. The gene discussed is SIRT2; the disease is melanoma.